Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.23M Sell
23,100
-69,600
-75% -$12.8M 0.01% 984
2025
Q4
$16.3M Buy
92,700
+15,000
+19% +$2.45M 0.03% 441
2025
Q3
$10.9M Sell
77,700
-13,900
-15% -$1.88M 0.02% 651
2025
Q2
$11.5M Buy
91,600
+83,600
+1,045% +$10.4M 0.02% 576
2025
Q1
$1.09M Buy
+8,000
New +$1.14M ﹤0.01% 1721

Other funds holding BIIB

PEAK6's BIIB Position: Q1 2026 in Review

PEAK6 opened a new position in Biogen (BIIB) in Q1 2026: 28,166 shares worth $5.16M. The stake represents 0.01% of the portfolio and ranks #885 among its holdings. This is a return to the name: PEAK6 previously reported a position in BIIB as recently as Q2 2025.

PEAK6 first reported a position in BIIB in Q4 2024 and has held it in 4 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • PEAK6 held 28,166 shares of Biogen worth $5.16M as of Q1 2026.
  • Biogen was a new PEAK6 position in Q1 2026.
  • Biogen made up 0.01% of PEAK6's portfolio in Q1 2026, its #885 holding.
  • PEAK6 first reported a position in Biogen in Q4 2024 and has held it in 4 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.